Interferon-Beta

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

6 competitors in Adrenoleukodystrophy

#DrugCompanyPhaseTrials

1

Mirapex

Boehringer Ingelheim

Approved

12

Cytoxan

BBaxter Healthcare Corporation

Approved

—3

Busulfex

Akero Therapeutics

Approved

—4

Thalomid

Bristol-Myers Squibb

Preclinical

15

DUOC-01

JJoanne Kurtzberg, MD

Phase 1

16

Interferon-Beta

Biogen

Preclinical

1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Multiple Sclerosis4 trials

Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta

Terminated·Sanofi·Phase 3·NCT01252355·534 enrolled

A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)

Completed·EMD Serono Research & Development Institute, Inc.·Phase 2·NCT00436826·172 enrolled

Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)

Unknown status·FFundació Institut Germans Trias i Pujol·Phase 1·NCT02903537·16 enrolled

Show 1 more trial

Multiple Sclerosis: Chi3L1 and Treatment Efficacy

Completed·—··NCT04289675·63 enrolled

Pregnancy1 trial

A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies

Recruiting·Biogen··NCT05688436·1,178 enrolled

Efficacy1 trial

Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II

Completed·FFaron Pharmaceuticals Ltd·Phase 1/2·NCT00789685·37 enrolled

COVID-191 trial

Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial

Completed·PPopulation Health Research Institute·Phase 3·NCT04324463·6,667 enrolled

Intermediate Uveitis1 trial

Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis

Completed·HHeidelberg University·Phase 3·NCT00344253·19 enrolled

2 more indications

Adrenoleukodystrophy1 trial

Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy

Completed·FFDA Office of Orphan Products Development·N/A·NCT00004450·60 enrolled

Unspecified1 trial

Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy

Withdrawn·Biogen·Phase 4·NCT02234869

Details

Drug Info

Related News